Clinical Trial Update: Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the safety and tolerability of brexpiprazole in adults with Borderline Personality Disorder has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Borderline Personality Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-10-03